Pau Abrisqueta

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

Umberto Vitolo, Marek Trněný, David Belada et al. · Journal of Clinical Oncology · 2017 · 424 citations

Medicine, Hematology, Oncology +12

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

David W. Scott, Anja Mottok, Daisuke Ennishi et al. · Journal of Clinical Oncology · 2015 · 406 citations · Full text

Medicine, Oncology, Pathology +17

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Panagiotis Baliakas, Sabine Jeromin, Michalis Iskas et al. · Blood · 2019 · 237 citations · Full text

Life Sciences, Hematology, Oncology +16

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior

Eva Giné, N. Villamor, Armando López‐Guillermo et al. · Haematologica · 2010 · 197 citations · Full text

Veterinary Medicine, Oncology, Pathology +13

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome

Neus Villamor, L Conde, Alejandra Martínez‐Trillos et al. · Leukemia · 2012 · 184 citations · Full text

Medicine, Genetics, Oncology +16